Playing the melanoma endgame

Treatments for melanoma are of two main types: targeted therapies and immune checkpoint inhibitors. However, both are only effective in a subset of patients and are limited by acquired resistance.  Here, the authors present the preclinical basis to broadly target different forms of therapy-resistant melanoma.